"进博会不是单项产品的行业展会，而是涉及众多领域的综合展会。能够跨越产业界限、与广泛的利益 相关者建立联系，是进博会特有的价值。"旭化成株式会社执行官、中国总代表五十岚弘之近日在旭化 成（中国）投资有限公司北京分公司接受经济日报记者采访时表示，旭化成是在多领域开展业务的综合 化学制造企业，进博会为公司在中国提供了全方位展示的机会。今年参展第八届进博会，希望继续与政 府、合作伙伴和客户展开更多交流，也期待通过进博会创造的契机，为公司带来更多发展机遇。 总部位于日本的旭化成是一家综合性化工制造商。今年已是连续4次参展进博会，将以"赋能多元材料， 共创新质生产力"为主题，展示其在汽车智造、数字发展、健康生活和低碳绿能四大领域的创新成果。 "以去年进博会为契机，我们的绿色印刷技术水洗印版AWP柔版印刷，目前正在与中国国内的品牌方共 同推进概念验证。今后也会继续稳健地推进这些业务，在创新方面加强与本土企业的合作。"五十岚弘 之说。 五十岚弘之透露，今年参展进博会的亮点之一，是展台上将设置一辆旭化成汽车解决方案体验车。"进 博会期间，我们希望与业界充分交流，也希望把我们的创新成果更直观地呈现给观众。在今年展示的体 验车上 ...

Group 1: Recent IPOs - Zhuoyuan, a corporate services company, successfully listed on NASDAQ, raising $5.6 million with a market capitalization of $32.11 million [1] - Wangsu Technology, a supply chain management service provider, listed on NASDAQ, raising $9.5 million with a market capitalization of $112 million [2] - Haixi New Drug, a pharmaceutical company, successfully listed on the Hong Kong Stock Exchange, raising approximately HK$994 million with a market capitalization of HK$8.603 billion [3] - Jushuitan, an e-commerce SaaS ERP provider, listed on the Hong Kong Stock Exchange, raising approximately HK$2.086 billion with a market capitalization of HK$14.852 billion [4] - Guanghetong, a wireless communication module provider, completed its "A+H" listing on the Hong Kong Stock Exchange, raising approximately HK$2.904 billion with a market capitalization of HK$24.891 billion [5] Group 2: Upcoming IPOs - Bama Tea, a high-end tea brand, plans to issue 9 million shares, aiming to raise approximately HK$428 million, with an expected listing date of October 28 on the Hong Kong Stock Exchange [6] - Cambridge Technology, a supplier of optical and wireless connection devices, plans to issue 67.01 million shares, aiming to raise approximately HK$4.616 billion, with an expected listing date of October 28 [7] - Dipu Technology, an AI application solution provider, plans to issue 26.63 million shares, aiming to raise approximately HK$710 million, with an expected listing date of October 28 [8] - Sany Heavy Industry, an engineering machinery company, plans to issue 580 million shares, aiming to raise approximately HK$12.064 billion, with an expected listing date of October 28 [9] - Minglue Technology, a data intelligence application software company, plans to issue 7.219 million shares, aiming to raise approximately HK$1.018 billion, with an expected listing date of November 3 [10] Group 3: Companies Filing for IPO - Sijiao Infrastructure Fund, a public open-end fund, filed for an IPO on the Hong Kong Stock Exchange, focusing on infrastructure investments [11] - Qingtian Quansuitong, a cross-border intelligent tax solution provider, filed for an IPO on the Hong Kong Stock Exchange, ranking first in the cross-border enterprise intelligent tax solution market [12] - Lakala, an independent digital payment service provider, filed for an IPO on the Hong Kong Stock Exchange, holding a 9.4% market share in the independent digital payment service sector [13] - Yuwang Biological Nutrition, a supplier of food-grade refined fish oil, filed for an IPO on the Hong Kong Stock Exchange, being the largest supplier in its category with an 8.1% market share [14] - Jintian Animation, an IP fun food company, filed for an IPO on the Hong Kong Stock Exchange, focusing on fun and healthy food products [15] Group 4: Companies Undergoing Hearing for IPO - Pony.ai, an autonomous driving technology company, passed the hearing for its IPO on the Hong Kong Stock Exchange, focusing on safe and reliable autonomous driving solutions [19] - Joyson Electronics, a smart automotive technology solution provider, passed the hearing for its IPO on the Hong Kong Stock Exchange, ranking second in the automotive passive safety product sector [20] - WeRide, an autonomous driving technology company, passed the hearing for its IPO on the Hong Kong Stock Exchange, ranking second in the global market for urban road L4-level autonomous driving [21] - Wangshan Wangshui, a biopharmaceutical company, passed the hearing for its IPO on the Hong Kong Stock Exchange, focusing on innovative small molecule drug development [22] - Baitian Tianheng, an innovative biopharmaceutical company, passed the hearing for its IPO on the Hong Kong Stock Exchange, developing ADC drugs and multi-specific antibody drugs [23] - Tianyu Semiconductor, a silicon carbide epitaxial wafer supplier, passed the hearing for its IPO on the Hong Kong Stock Exchange, holding a 38.8% market share in the silicon carbide epitaxial wafer market [24] Group 5: Companies Approved for Filing - Six companies, including Naxin Micro and Baiguoyuan, received approval for overseas IPOs and domestic unlisted shares "full circulation" filing from the China Securities Regulatory Commission [25]